Biomerica (BMRA) Operating Leases (2019 - 2025)

Biomerica (BMRA) reported Operating Leases of $373000.0 for Q3 2025, little changed on a YoY basis from $373000.0 in Q3 2024, and up 273.0% sequentially from $100000.0 in Q2 2025.

Biomerica (BMRA) Operating Leases (2019 - 2025) Analysis & Trends

Biomerica (BMRA) has 7 years of Operating Leases data on file, last reported at $373000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases changed 0.0% year-over-year to $373000.0; the trailing twelve-month figure through Aug 2025 stood at $373000.0 (changed 0.0% YoY), and the FY2025 full-year result was $100000.0, down 78.21% from the prior year.
  • Operating Leases improved to $373000.0 in Q3 2025, from $100000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.6 million in Q3 2021 to a low of $100000.0 in Q2 2025.
  • A 5-year average of $878839.0 and a median of $901449.0 in 2022 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases grew 3.94% in 2023 and slumped 78.21% in 2025, its largest moves.
  • Tracing BMRA's Operating Leases over 5 years: stood at $1.5 million in 2021, then slumped by 39.98% to $901449.0 in 2022, then rose by 3.94% to $937000.0 in 2023, then sank by 33.19% to $626000.0 in 2024, then sank by 40.42% to $373000.0 in 2025.
  • Business Quant data shows BMRA's Operating Leases at $373000.0 in Q3 2025, $100000.0 in Q2 2025, and $193000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Biomerica 4.85 Mn 3.51 Mn -44,000.00

Historic Data

Download Data
DateValue
Aug 31, 2025 373,000.00
May 31, 2025 100,000.00
Feb 28, 2025 193,000.00
Nov 30, 2024 626,000.00
Aug 31, 2024 373,000.00
May 31, 2024 459,000.00
Feb 29, 2024 862,000.00
Nov 30, 2023 937,000.00
Aug 31, 2023 705,000.00
May 31, 2023 785,000.00
Feb 28, 2023 1.18 Mn
Nov 30, 2022 901,449.00
Aug 31, 2022 970,890.00
May 31, 2022 1.04 Mn
Feb 28, 2022 1.44 Mn
Nov 30, 2021 1.50 Mn
Aug 31, 2021 1.56 Mn
May 31, 2021 1.29 Mn
Feb 28, 2021 1.40 Mn
Nov 30, 2020 1.45 Mn